Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
1996

Comparing Methods for Assessing Oestrogen Receptors in Breast Cancer

Sample size: 170 publication Evidence: high

Author Information

Author(s): DM Barnes, WH Harris, P Smith, RR Millis, RD Rubens

Primary Institution: Imperial Cancer Research Fund, Clinical Oncology Unit, Guy's Hospital, London, UK

Hypothesis

Which method of assessing oestrogen receptor staining correlates best with clinical outcomes in breast cancer patients?

Conclusion

Immunohistochemical assays for oestrogen receptors provide more clinically relevant results than traditional cytosol assays.

Supporting Evidence

  • Immunohistochemical assays showed a higher percentage of ER-positive cases compared to cytosol assays.
  • 51% of patients showed a complete or partial response to tamoxifen treatment.
  • Statistical analysis indicated significant correlations between ER status and clinical outcomes.
  • Different scoring methods for immunohistochemistry yielded varying results, highlighting the need for standardization.

Takeaway

This study looked at different ways to check for a protein in breast cancer that helps doctors decide on treatment. They found that one new method works better than the old one.

Methodology

The study involved staining breast cancer tissue from 170 women with tamoxifen treatment using various methods to assess oestrogen receptor status and comparing these results with clinical outcomes.

Potential Biases

Potential bias in patient selection as only those with evaluable metastatic breast cancer were included.

Limitations

The study was limited to women who had already shown a response to hormone treatment, which may not represent the general population of breast cancer patients.

Participant Demographics

170 women with metastatic breast cancer, including 133 with operable primary disease, 23 with locally advanced disease, and 14 with distant metastases.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication